Skip to main content
  • Bioresorbable Stents: Now Just a 'Niche Product' Still, Absorb's competitors push for thinner, safer BVS

    With one company now pulling back from the race to develop bioresorbable vascular scaffolds (BVS), Abbott’s competitors may be having second thoughts on the safety of this technology.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details